nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ALB—hepatitis B	0.235	1	CbGaD
Imatinib—SLC22A2—Lamivudine—hepatitis B	0.109	0.348	CbGbCtD
Imatinib—SLC22A1—Lamivudine—hepatitis B	0.0943	0.302	CbGbCtD
Imatinib—ABCG2—Lamivudine—hepatitis B	0.0801	0.257	CbGbCtD
Imatinib—ABCB1—Lamivudine—hepatitis B	0.0289	0.0926	CbGbCtD
Imatinib—CA6—saliva—hepatitis B	0.0106	0.127	CbGeAlD
Imatinib—ORM1—saliva—hepatitis B	0.00566	0.0678	CbGeAlD
Imatinib—CSF1R—blood plasma—hepatitis B	0.00296	0.0355	CbGeAlD
Imatinib—ABCA3—blood—hepatitis B	0.00295	0.0354	CbGeAlD
Imatinib—DDR1—blood—hepatitis B	0.00272	0.0326	CbGeAlD
Imatinib—KIT—blood plasma—hepatitis B	0.00269	0.0322	CbGeAlD
Imatinib—CA1—blood plasma—hepatitis B	0.00246	0.0295	CbGeAlD
Imatinib—DDR1—liver—hepatitis B	0.00213	0.0255	CbGeAlD
Imatinib—ABL2—blood—hepatitis B	0.00178	0.0213	CbGeAlD
Imatinib—CYP2C19—blood plasma—hepatitis B	0.00174	0.0208	CbGeAlD
Imatinib—PIP4K2C—blood—hepatitis B	0.00168	0.0202	CbGeAlD
Imatinib—CA2—blood plasma—hepatitis B	0.00159	0.0191	CbGeAlD
Imatinib—LCK—blood—hepatitis B	0.00149	0.0179	CbGeAlD
Imatinib—CYP1A2—blood plasma—hepatitis B	0.00142	0.017	CbGeAlD
Imatinib—ABL2—liver—hepatitis B	0.00139	0.0167	CbGeAlD
Imatinib—CYP3A5—blood plasma—hepatitis B	0.00137	0.0164	CbGeAlD
Imatinib—CYP2C9—blood plasma—hepatitis B	0.00135	0.0162	CbGeAlD
Imatinib—Myopathy—Lamivudine—hepatitis B	0.00132	0.00568	CcSEcCtD
Imatinib—PIP4K2C—liver—hepatitis B	0.00131	0.0158	CbGeAlD
Imatinib—Throat sore—Lamivudine—hepatitis B	0.00129	0.00553	CcSEcCtD
Imatinib—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00127	0.00548	CcSEcCtD
Imatinib—CA3—liver—hepatitis B	0.00125	0.015	CbGeAlD
Imatinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00125	0.00537	CcSEcCtD
Imatinib—NQO2—blood—hepatitis B	0.00123	0.0148	CbGeAlD
Imatinib—PDGFRA—blood—hepatitis B	0.00123	0.0148	CbGeAlD
Imatinib—Pancreatitis—Entecavir—hepatitis B	0.00123	0.00529	CcSEcCtD
Imatinib—PTGS1—blood plasma—hepatitis B	0.00123	0.0148	CbGeAlD
Imatinib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.0012	0.00516	CcSEcCtD
Imatinib—Pain in extremity—Telbivudine—hepatitis B	0.00119	0.00513	CcSEcCtD
Imatinib—Hyperaesthesia—Lamivudine—hepatitis B	0.00118	0.00507	CcSEcCtD
Imatinib—Migraine—Telbivudine—hepatitis B	0.00117	0.00505	CcSEcCtD
Imatinib—Neutropenia—Entecavir—hepatitis B	0.00117	0.00505	CcSEcCtD
Imatinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00117	0.00502	CcSEcCtD
Imatinib—LCK—liver—hepatitis B	0.00117	0.014	CbGeAlD
Imatinib—CA14—liver—hepatitis B	0.00114	0.0137	CbGeAlD
Imatinib—Hyperglycaemia—Entecavir—hepatitis B	0.00113	0.00487	CcSEcCtD
Imatinib—CYP3A7—liver—hepatitis B	0.00111	0.0134	CbGeAlD
Imatinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00111	0.00476	CcSEcCtD
Imatinib—Renal failure—Entecavir—hepatitis B	0.0011	0.00473	CcSEcCtD
Imatinib—Abdominal pain upper—Telbivudine—hepatitis B	0.00109	0.00468	CcSEcCtD
Imatinib—CSF1R—blood—hepatitis B	0.00108	0.013	CbGeAlD
Imatinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00107	0.00462	CcSEcCtD
Imatinib—Cramp muscle—Telbivudine—hepatitis B	0.00107	0.00462	CcSEcCtD
Imatinib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00107	0.00462	CcSEcCtD
Imatinib—Haematuria—Entecavir—hepatitis B	0.00107	0.00459	CcSEcCtD
Imatinib—Nasopharyngitis—Telbivudine—hepatitis B	0.00107	0.00459	CcSEcCtD
Imatinib—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00106	0.00458	CcSEcCtD
Imatinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00106	0.00455	CcSEcCtD
Imatinib—Gastritis—Telbivudine—hepatitis B	0.00106	0.00454	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00105	0.00452	CcSEcCtD
Imatinib—Muscular weakness—Telbivudine—hepatitis B	0.00105	0.00452	CcSEcCtD
Imatinib—Rhabdomyolysis—Lamivudine—hepatitis B	0.00105	0.0045	CcSEcCtD
Imatinib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00104	0.00448	CcSEcCtD
Imatinib—Abdominal distension—Telbivudine—hepatitis B	0.00104	0.00446	CcSEcCtD
Imatinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00103	0.00444	CcSEcCtD
Imatinib—Influenza—Telbivudine—hepatitis B	0.00103	0.00443	CcSEcCtD
Imatinib—CYP3A4—blood plasma—hepatitis B	0.00103	0.0123	CbGeAlD
Imatinib—Bone disorder—Lamivudine—hepatitis B	0.00103	0.00441	CcSEcCtD
Imatinib—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00102	0.0044	CcSEcCtD
Imatinib—Oropharyngeal pain—Lamivudine—hepatitis B	0.00102	0.00438	CcSEcCtD
Imatinib—CYP2D6—blood plasma—hepatitis B	0.00101	0.0121	CbGeAlD
Imatinib—Hepatitis—Entecavir—hepatitis B	0.00101	0.00432	CcSEcCtD
Imatinib—Drug interaction—Lamivudine—hepatitis B	0.000999	0.00429	CcSEcCtD
Imatinib—Oedema peripheral—Entecavir—hepatitis B	0.00099	0.00426	CcSEcCtD
Imatinib—SLC47A1—blood—hepatitis B	0.00099	0.0119	CbGeAlD
Imatinib—KIT—blood—hepatitis B	0.000984	0.0118	CbGeAlD
Imatinib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000981	0.00421	CcSEcCtD
Imatinib—Hearing impaired—Lamivudine—hepatitis B	0.000973	0.00418	CcSEcCtD
Imatinib—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000973	0.00418	CcSEcCtD
Imatinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000968	0.00416	CcSEcCtD
Imatinib—NQO2—liver—hepatitis B	0.000965	0.0116	CbGeAlD
Imatinib—Neutropenia—Telbivudine—hepatitis B	0.000965	0.00415	CcSEcCtD
Imatinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000964	0.00414	CcSEcCtD
Imatinib—PDGFRA—liver—hepatitis B	0.000963	0.0115	CbGeAlD
Imatinib—PDGFRB—blood—hepatitis B	0.000961	0.0115	CbGeAlD
Imatinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000961	0.00413	CcSEcCtD
Imatinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000959	0.00412	CcSEcCtD
Imatinib—Vasculitis—Lamivudine—hepatitis B	0.000949	0.00408	CcSEcCtD
Imatinib—CYP3A7-CYP3A51P—liver—hepatitis B	0.000948	0.0114	CbGeAlD
Imatinib—Musculoskeletal pain—Lamivudine—hepatitis B	0.000938	0.00403	CcSEcCtD
Imatinib—Eructation—Lamivudine—hepatitis B	0.00091	0.00391	CcSEcCtD
Imatinib—Immune system disorder—Entecavir—hepatitis B	0.000908	0.0039	CcSEcCtD
Imatinib—Renal failure—Telbivudine—hepatitis B	0.000904	0.00389	CcSEcCtD
Imatinib—ORM1—blood—hepatitis B	0.000902	0.0108	CbGeAlD
Imatinib—Neuropathy peripheral—Telbivudine—hepatitis B	0.000902	0.00387	CcSEcCtD
Imatinib—CA1—blood—hepatitis B	0.0009	0.0108	CbGeAlD
Imatinib—Alopecia—Entecavir—hepatitis B	0.000888	0.00382	CcSEcCtD
Imatinib—Mental disorder—Entecavir—hepatitis B	0.000881	0.00378	CcSEcCtD
Imatinib—Malnutrition—Entecavir—hepatitis B	0.000875	0.00376	CcSEcCtD
Imatinib—Aplastic anaemia—Lamivudine—hepatitis B	0.00087	0.00374	CcSEcCtD
Imatinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00087	0.00374	CcSEcCtD
Imatinib—ABL1—blood—hepatitis B	0.000857	0.0103	CbGeAlD
Imatinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000854	0.00367	CcSEcCtD
Imatinib—CSF1R—liver—hepatitis B	0.000848	0.0102	CbGeAlD
Imatinib—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000841	0.00362	CcSEcCtD
Imatinib—Mouth ulceration—Lamivudine—hepatitis B	0.000838	0.0036	CcSEcCtD
Imatinib—Gynaecomastia—Lamivudine—hepatitis B	0.000829	0.00356	CcSEcCtD
Imatinib—SLC22A1—blood—hepatitis B	0.000826	0.0099	CbGeAlD
Imatinib—Back pain—Adefovir Dipivoxil—hepatitis B	0.000826	0.00355	CcSEcCtD
Imatinib—Hepatitis—Telbivudine—hepatitis B	0.000826	0.00355	CcSEcCtD
Imatinib—Hypoaesthesia—Telbivudine—hepatitis B	0.000822	0.00353	CcSEcCtD
Imatinib—Pharyngitis—Telbivudine—hepatitis B	0.00082	0.00352	CcSEcCtD
Imatinib—Connective tissue disorder—Telbivudine—hepatitis B	0.000811	0.00349	CcSEcCtD
Imatinib—Sepsis—Lamivudine—hepatitis B	0.000804	0.00346	CcSEcCtD
Imatinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000789	0.00339	CcSEcCtD
Imatinib—Lymphadenopathy—Lamivudine—hepatitis B	0.000788	0.00339	CcSEcCtD
Imatinib—Leukopenia—Entecavir—hepatitis B	0.000783	0.00337	CcSEcCtD
Imatinib—SLC47A1—liver—hepatitis B	0.000774	0.00928	CbGeAlD
Imatinib—KIT—liver—hepatitis B	0.00077	0.00923	CbGeAlD
Imatinib—Gastroenteritis—Lamivudine—hepatitis B	0.000759	0.00326	CcSEcCtD
Imatinib—Deafness—Lamivudine—hepatitis B	0.000752	0.00323	CcSEcCtD
Imatinib—PDGFRB—liver—hepatitis B	0.000752	0.00901	CbGeAlD
Imatinib—Cough—Adefovir Dipivoxil—hepatitis B	0.000745	0.0032	CcSEcCtD
Imatinib—Mediastinal disorder—Telbivudine—hepatitis B	0.000744	0.0032	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00074	0.00318	CcSEcCtD
Imatinib—ABCB1—blood plasma—hepatitis B	0.000727	0.00872	CbGeAlD
Imatinib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000727	0.00312	CcSEcCtD
Imatinib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000727	0.00312	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000722	0.0031	CcSEcCtD
Imatinib—Malnutrition—Telbivudine—hepatitis B	0.000719	0.00309	CcSEcCtD
Imatinib—Anaphylactic shock—Entecavir—hepatitis B	0.000714	0.00307	CcSEcCtD
Imatinib—Infection—Entecavir—hepatitis B	0.000709	0.00305	CcSEcCtD
Imatinib—ORM1—liver—hepatitis B	0.000705	0.00846	CbGeAlD
Imatinib—CA1—liver—hepatitis B	0.000704	0.00844	CbGeAlD
Imatinib—Dysgeusia—Telbivudine—hepatitis B	0.000704	0.00303	CcSEcCtD
Imatinib—Nervous system disorder—Entecavir—hepatitis B	0.0007	0.00301	CcSEcCtD
Imatinib—Back pain—Telbivudine—hepatitis B	0.000695	0.00299	CcSEcCtD
Imatinib—Skin disorder—Entecavir—hepatitis B	0.000694	0.00298	CcSEcCtD
Imatinib—Muscle spasms—Telbivudine—hepatitis B	0.000691	0.00297	CcSEcCtD
Imatinib—Hypoglycaemia—Lamivudine—hepatitis B	0.000689	0.00296	CcSEcCtD
Imatinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000683	0.00294	CcSEcCtD
Imatinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000682	0.00293	CcSEcCtD
Imatinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000677	0.00291	CcSEcCtD
Imatinib—ABL1—liver—hepatitis B	0.00067	0.00803	CbGeAlD
Imatinib—Ill-defined disorder—Telbivudine—hepatitis B	0.000667	0.00287	CcSEcCtD
Imatinib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000664	0.00285	CcSEcCtD
Imatinib—Migraine—Lamivudine—hepatitis B	0.000662	0.00285	CcSEcCtD
Imatinib—Malaise—Telbivudine—hepatitis B	0.000648	0.00279	CcSEcCtD
Imatinib—SLC22A1—liver—hepatitis B	0.000646	0.00775	CbGeAlD
Imatinib—Insomnia—Entecavir—hepatitis B	0.000646	0.00278	CcSEcCtD
Imatinib—CYP2C19—blood—hepatitis B	0.000637	0.00763	CbGeAlD
Imatinib—Somnolence—Entecavir—hepatitis B	0.000635	0.00273	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000635	0.00273	CcSEcCtD
Imatinib—Dyspepsia—Entecavir—hepatitis B	0.000629	0.0027	CcSEcCtD
Imatinib—Cough—Telbivudine—hepatitis B	0.000627	0.0027	CcSEcCtD
Imatinib—Dehydration—Lamivudine—hepatitis B	0.000626	0.00269	CcSEcCtD
Imatinib—ALB—liver—hepatitis B	0.000618	0.00741	CbGeAlD
Imatinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.000617	0.00265	CcSEcCtD
Imatinib—Fatigue—Entecavir—hepatitis B	0.000616	0.00265	CcSEcCtD
Imatinib—Abdominal pain upper—Lamivudine—hepatitis B	0.000614	0.00264	CcSEcCtD
Imatinib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000613	0.00264	CcSEcCtD
Imatinib—Arthralgia—Telbivudine—hepatitis B	0.000612	0.00263	CcSEcCtD
Imatinib—Chest pain—Telbivudine—hepatitis B	0.000612	0.00263	CcSEcCtD
Imatinib—Myalgia—Telbivudine—hepatitis B	0.000612	0.00263	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000608	0.00261	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000606	0.0026	CcSEcCtD
Imatinib—Cramp muscle—Lamivudine—hepatitis B	0.000606	0.0026	CcSEcCtD
Imatinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000606	0.0026	CcSEcCtD
Imatinib—Discomfort—Telbivudine—hepatitis B	0.000605	0.0026	CcSEcCtD
Imatinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000602	0.00259	CcSEcCtD
Imatinib—Nasopharyngitis—Lamivudine—hepatitis B	0.000601	0.00259	CcSEcCtD
Imatinib—Muscular weakness—Lamivudine—hepatitis B	0.000593	0.00255	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000593	0.00255	CcSEcCtD
Imatinib—Abdominal distension—Lamivudine—hepatitis B	0.000585	0.00252	CcSEcCtD
Imatinib—Gastrointestinal pain—Entecavir—hepatitis B	0.000584	0.00251	CcSEcCtD
Imatinib—CA2—blood—hepatitis B	0.000583	0.007	CbGeAlD
Imatinib—Dysphagia—Lamivudine—hepatitis B	0.000581	0.0025	CcSEcCtD
Imatinib—Influenza—Lamivudine—hepatitis B	0.000581	0.0025	CcSEcCtD
Imatinib—Nervous system disorder—Telbivudine—hepatitis B	0.000575	0.00247	CcSEcCtD
Imatinib—Thrombocytopenia—Telbivudine—hepatitis B	0.000574	0.00247	CcSEcCtD
Imatinib—Pancreatitis—Lamivudine—hepatitis B	0.00057	0.00245	CcSEcCtD
Imatinib—Skin disorder—Telbivudine—hepatitis B	0.00057	0.00245	CcSEcCtD
Imatinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00057	0.00245	CcSEcCtD
Imatinib—Sweating increased—Lamivudine—hepatitis B	0.000566	0.00243	CcSEcCtD
Imatinib—Body temperature increased—Entecavir—hepatitis B	0.000565	0.00243	CcSEcCtD
Imatinib—Abdominal pain—Entecavir—hepatitis B	0.000565	0.00243	CcSEcCtD
Imatinib—Pancytopenia—Lamivudine—hepatitis B	0.000552	0.00237	CcSEcCtD
Imatinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000551	0.00237	CcSEcCtD
Imatinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000551	0.00237	CcSEcCtD
Imatinib—Neutropenia—Lamivudine—hepatitis B	0.000544	0.00234	CcSEcCtD
Imatinib—ABCG2—blood—hepatitis B	0.00054	0.00648	CbGeAlD
Imatinib—Pollakiuria—Lamivudine—hepatitis B	0.000537	0.00231	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000534	0.0023	CcSEcCtD
Imatinib—Insomnia—Telbivudine—hepatitis B	0.000531	0.00228	CcSEcCtD
Imatinib—Paraesthesia—Telbivudine—hepatitis B	0.000527	0.00226	CcSEcCtD
Imatinib—Hyperglycaemia—Lamivudine—hepatitis B	0.000524	0.00225	CcSEcCtD
Imatinib—CYP1A2—blood—hepatitis B	0.00052	0.00624	CbGeAlD
Imatinib—Depression—Lamivudine—hepatitis B	0.000517	0.00222	CcSEcCtD
Imatinib—Dyspepsia—Telbivudine—hepatitis B	0.000516	0.00222	CcSEcCtD
Imatinib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000514	0.00221	CcSEcCtD
Imatinib—Asthenia—Entecavir—hepatitis B	0.000512	0.0022	CcSEcCtD
Imatinib—Renal failure—Lamivudine—hepatitis B	0.00051	0.00219	CcSEcCtD
Imatinib—Neuropathy peripheral—Lamivudine—hepatitis B	0.000508	0.00218	CcSEcCtD
Imatinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000506	0.00218	CcSEcCtD
Imatinib—Fatigue—Telbivudine—hepatitis B	0.000506	0.00217	CcSEcCtD
Imatinib—Stomatitis—Lamivudine—hepatitis B	0.000505	0.00217	CcSEcCtD
Imatinib—Jaundice—Lamivudine—hepatitis B	0.000505	0.00217	CcSEcCtD
Imatinib—Pain—Telbivudine—hepatitis B	0.000502	0.00216	CcSEcCtD
Imatinib—CYP3A5—blood—hepatitis B	0.000502	0.00601	CbGeAlD
Imatinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0005	0.00215	CcSEcCtD
Imatinib—CYP2C19—liver—hepatitis B	0.000498	0.00597	CbGeAlD
Imatinib—Sweating—Lamivudine—hepatitis B	0.000497	0.00214	CcSEcCtD
Imatinib—CYP2C9—blood—hepatitis B	0.000494	0.00592	CbGeAlD
Imatinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000493	0.00212	CcSEcCtD
Imatinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00049	0.00211	CcSEcCtD
Imatinib—Epistaxis—Lamivudine—hepatitis B	0.000489	0.0021	CcSEcCtD
Imatinib—Diarrhoea—Entecavir—hepatitis B	0.000489	0.0021	CcSEcCtD
Imatinib—Sinusitis—Lamivudine—hepatitis B	0.000486	0.00209	CcSEcCtD
Imatinib—Agranulocytosis—Lamivudine—hepatitis B	0.000484	0.00208	CcSEcCtD
Imatinib—Feeling abnormal—Telbivudine—hepatitis B	0.000483	0.00208	CcSEcCtD
Imatinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00048	0.00206	CcSEcCtD
Imatinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000477	0.00205	CcSEcCtD
Imatinib—Dizziness—Entecavir—hepatitis B	0.000472	0.00203	CcSEcCtD
Imatinib—Rhinitis—Lamivudine—hepatitis B	0.000467	0.002	CcSEcCtD
Imatinib—Hepatitis—Lamivudine—hepatitis B	0.000465	0.002	CcSEcCtD
Imatinib—Abdominal pain—Telbivudine—hepatitis B	0.000464	0.00199	CcSEcCtD
Imatinib—Body temperature increased—Telbivudine—hepatitis B	0.000464	0.00199	CcSEcCtD
Imatinib—Hypoaesthesia—Lamivudine—hepatitis B	0.000463	0.00199	CcSEcCtD
Imatinib—Pharyngitis—Lamivudine—hepatitis B	0.000462	0.00198	CcSEcCtD
Imatinib—Connective tissue disorder—Lamivudine—hepatitis B	0.000457	0.00197	CcSEcCtD
Imatinib—CA2—liver—hepatitis B	0.000456	0.00547	CbGeAlD
Imatinib—Vomiting—Entecavir—hepatitis B	0.000454	0.00195	CcSEcCtD
Imatinib—PTGS1—blood—hepatitis B	0.000451	0.0054	CbGeAlD
Imatinib—Rash—Entecavir—hepatitis B	0.00045	0.00194	CcSEcCtD
Imatinib—Dermatitis—Entecavir—hepatitis B	0.00045	0.00193	CcSEcCtD
Imatinib—Headache—Entecavir—hepatitis B	0.000447	0.00192	CcSEcCtD
Imatinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000443	0.0019	CcSEcCtD
Imatinib—Erythema multiforme—Lamivudine—hepatitis B	0.00044	0.00189	CcSEcCtD
Imatinib—Rash—Adefovir Dipivoxil—hepatitis B	0.000439	0.00189	CcSEcCtD
Imatinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000439	0.00189	CcSEcCtD
Imatinib—Headache—Adefovir Dipivoxil—hepatitis B	0.000436	0.00188	CcSEcCtD
Imatinib—Nausea—Entecavir—hepatitis B	0.000424	0.00182	CcSEcCtD
Imatinib—ABCG2—liver—hepatitis B	0.000423	0.00507	CbGeAlD
Imatinib—Asthenia—Telbivudine—hepatitis B	0.000421	0.00181	CcSEcCtD
Imatinib—Immune system disorder—Lamivudine—hepatitis B	0.00042	0.00181	CcSEcCtD
Imatinib—Mediastinal disorder—Lamivudine—hepatitis B	0.000419	0.0018	CcSEcCtD
Imatinib—Chills—Lamivudine—hepatitis B	0.000418	0.00179	CcSEcCtD
Imatinib—Pruritus—Telbivudine—hepatitis B	0.000415	0.00178	CcSEcCtD
Imatinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.000414	0.00178	CcSEcCtD
Imatinib—Alopecia—Lamivudine—hepatitis B	0.000411	0.00177	CcSEcCtD
Imatinib—CYP1A2—liver—hepatitis B	0.000407	0.00488	CbGeAlD
Imatinib—Malnutrition—Lamivudine—hepatitis B	0.000405	0.00174	CcSEcCtD
Imatinib—Erythema—Lamivudine—hepatitis B	0.000405	0.00174	CcSEcCtD
Imatinib—Diarrhoea—Telbivudine—hepatitis B	0.000401	0.00172	CcSEcCtD
Imatinib—Flatulence—Lamivudine—hepatitis B	0.000399	0.00172	CcSEcCtD
Imatinib—Dysgeusia—Lamivudine—hepatitis B	0.000397	0.0017	CcSEcCtD
Imatinib—CYP3A5—liver—hepatitis B	0.000392	0.0047	CbGeAlD
Imatinib—Back pain—Lamivudine—hepatitis B	0.000392	0.00168	CcSEcCtD
Imatinib—Muscle spasms—Lamivudine—hepatitis B	0.000389	0.00167	CcSEcCtD
Imatinib—Dizziness—Telbivudine—hepatitis B	0.000388	0.00167	CcSEcCtD
Imatinib—CYP2C9—liver—hepatitis B	0.000386	0.00463	CbGeAlD
Imatinib—Tremor—Lamivudine—hepatitis B	0.00038	0.00163	CcSEcCtD
Imatinib—CYP3A4—blood—hepatitis B	0.000376	0.00451	CbGeAlD
Imatinib—Ill-defined disorder—Lamivudine—hepatitis B	0.000376	0.00162	CcSEcCtD
Imatinib—Anaemia—Lamivudine—hepatitis B	0.000374	0.00161	CcSEcCtD
Imatinib—Vomiting—Telbivudine—hepatitis B	0.000373	0.0016	CcSEcCtD
Imatinib—CYP2D6—blood—hepatitis B	0.00037	0.00444	CbGeAlD
Imatinib—Angioedema—Lamivudine—hepatitis B	0.00037	0.00159	CcSEcCtD
Imatinib—Rash—Telbivudine—hepatitis B	0.00037	0.00159	CcSEcCtD
Imatinib—Dermatitis—Telbivudine—hepatitis B	0.00037	0.00159	CcSEcCtD
Imatinib—Headache—Telbivudine—hepatitis B	0.000368	0.00158	CcSEcCtD
Imatinib—Malaise—Lamivudine—hepatitis B	0.000365	0.00157	CcSEcCtD
Imatinib—Vertigo—Lamivudine—hepatitis B	0.000364	0.00156	CcSEcCtD
Imatinib—Syncope—Lamivudine—hepatitis B	0.000363	0.00156	CcSEcCtD
Imatinib—Leukopenia—Lamivudine—hepatitis B	0.000363	0.00156	CcSEcCtD
Imatinib—Loss of consciousness—Lamivudine—hepatitis B	0.000356	0.00153	CcSEcCtD
Imatinib—Cough—Lamivudine—hepatitis B	0.000353	0.00152	CcSEcCtD
Imatinib—Convulsion—Lamivudine—hepatitis B	0.000351	0.00151	CcSEcCtD
Imatinib—Nausea—Telbivudine—hepatitis B	0.000348	0.0015	CcSEcCtD
Imatinib—Chest pain—Lamivudine—hepatitis B	0.000345	0.00148	CcSEcCtD
Imatinib—Myalgia—Lamivudine—hepatitis B	0.000345	0.00148	CcSEcCtD
Imatinib—Arthralgia—Lamivudine—hepatitis B	0.000345	0.00148	CcSEcCtD
Imatinib—Anxiety—Lamivudine—hepatitis B	0.000344	0.00148	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000342	0.00147	CcSEcCtD
Imatinib—Discomfort—Lamivudine—hepatitis B	0.000341	0.00146	CcSEcCtD
Imatinib—Dry mouth—Lamivudine—hepatitis B	0.000337	0.00145	CcSEcCtD
Imatinib—Confusional state—Lamivudine—hepatitis B	0.000333	0.00143	CcSEcCtD
Imatinib—Oedema—Lamivudine—hepatitis B	0.000331	0.00142	CcSEcCtD
Imatinib—Anaphylactic shock—Lamivudine—hepatitis B	0.000331	0.00142	CcSEcCtD
Imatinib—Infection—Lamivudine—hepatitis B	0.000328	0.00141	CcSEcCtD
Imatinib—Shock—Lamivudine—hepatitis B	0.000325	0.0014	CcSEcCtD
Imatinib—Nervous system disorder—Lamivudine—hepatitis B	0.000324	0.00139	CcSEcCtD
Imatinib—Thrombocytopenia—Lamivudine—hepatitis B	0.000324	0.00139	CcSEcCtD
Imatinib—Skin disorder—Lamivudine—hepatitis B	0.000321	0.00138	CcSEcCtD
Imatinib—Hyperhidrosis—Lamivudine—hepatitis B	0.00032	0.00137	CcSEcCtD
Imatinib—Anorexia—Lamivudine—hepatitis B	0.000315	0.00135	CcSEcCtD
Imatinib—Hypotension—Lamivudine—hepatitis B	0.000309	0.00133	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000301	0.00129	CcSEcCtD
Imatinib—Insomnia—Lamivudine—hepatitis B	0.000299	0.00129	CcSEcCtD
Imatinib—Paraesthesia—Lamivudine—hepatitis B	0.000297	0.00128	CcSEcCtD
Imatinib—Dyspnoea—Lamivudine—hepatitis B	0.000295	0.00127	CcSEcCtD
Imatinib—CYP3A4—liver—hepatitis B	0.000294	0.00353	CbGeAlD
Imatinib—Somnolence—Lamivudine—hepatitis B	0.000294	0.00126	CcSEcCtD
Imatinib—Dyspepsia—Lamivudine—hepatitis B	0.000291	0.00125	CcSEcCtD
Imatinib—CYP2D6—liver—hepatitis B	0.00029	0.00347	CbGeAlD
Imatinib—Decreased appetite—Lamivudine—hepatitis B	0.000287	0.00124	CcSEcCtD
Imatinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000285	0.00123	CcSEcCtD
Imatinib—Fatigue—Lamivudine—hepatitis B	0.000285	0.00122	CcSEcCtD
Imatinib—Constipation—Lamivudine—hepatitis B	0.000283	0.00121	CcSEcCtD
Imatinib—Pain—Lamivudine—hepatitis B	0.000283	0.00121	CcSEcCtD
Imatinib—Feeling abnormal—Lamivudine—hepatitis B	0.000272	0.00117	CcSEcCtD
Imatinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.00027	0.00116	CcSEcCtD
Imatinib—ABCB1—blood—hepatitis B	0.000266	0.00319	CbGeAlD
Imatinib—Urticaria—Lamivudine—hepatitis B	0.000263	0.00113	CcSEcCtD
Imatinib—Body temperature increased—Lamivudine—hepatitis B	0.000261	0.00112	CcSEcCtD
Imatinib—Abdominal pain—Lamivudine—hepatitis B	0.000261	0.00112	CcSEcCtD
Imatinib—Hypersensitivity—Lamivudine—hepatitis B	0.000244	0.00105	CcSEcCtD
Imatinib—Asthenia—Lamivudine—hepatitis B	0.000237	0.00102	CcSEcCtD
Imatinib—Pruritus—Lamivudine—hepatitis B	0.000234	0.00101	CcSEcCtD
Imatinib—Diarrhoea—Lamivudine—hepatitis B	0.000226	0.000972	CcSEcCtD
Imatinib—Dizziness—Lamivudine—hepatitis B	0.000219	0.00094	CcSEcCtD
Imatinib—Vomiting—Lamivudine—hepatitis B	0.00021	0.000903	CcSEcCtD
Imatinib—Rash—Lamivudine—hepatitis B	0.000208	0.000896	CcSEcCtD
Imatinib—ABCB1—liver—hepatitis B	0.000208	0.0025	CbGeAlD
Imatinib—Dermatitis—Lamivudine—hepatitis B	0.000208	0.000895	CcSEcCtD
Imatinib—Headache—Lamivudine—hepatitis B	0.000207	0.00089	CcSEcCtD
Imatinib—Nausea—Lamivudine—hepatitis B	0.000196	0.000844	CcSEcCtD
Imatinib—PDGFRB—Immune System—HLA-DRB1—hepatitis B	1.81e-05	0.000132	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—F2—hepatitis B	1.81e-05	0.000132	CbGpPWpGaD
Imatinib—LCK—Immune System—CD40LG—hepatitis B	1.81e-05	0.000132	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IL2—hepatitis B	1.8e-05	0.000131	CbGpPWpGaD
Imatinib—LCK—Immune System—CD8A—hepatitis B	1.79e-05	0.00013	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS2—hepatitis B	1.77e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Immune System—TLR4—hepatitis B	1.77e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-DRB1—hepatitis B	1.77e-05	0.000129	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT2—hepatitis B	1.77e-05	0.000129	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD4—hepatitis B	1.76e-05	0.000128	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT2—hepatitis B	1.75e-05	0.000128	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT2—hepatitis B	1.75e-05	0.000128	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TGFB1—hepatitis B	1.74e-05	0.000127	CbGpPWpGaD
Imatinib—CA9—Metabolism—ALB—hepatitis B	1.73e-05	0.000126	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ALB—hepatitis B	1.72e-05	0.000125	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TGFB1—hepatitis B	1.71e-05	0.000124	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL6—hepatitis B	1.7e-05	0.000124	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL10—hepatitis B	1.7e-05	0.000124	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD4—hepatitis B	1.69e-05	0.000123	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—IL6—hepatitis B	1.67e-05	0.000122	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GGT1—hepatitis B	1.64e-05	0.00012	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT1—hepatitis B	1.64e-05	0.00012	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.63e-05	0.000119	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT1—hepatitis B	1.63e-05	0.000118	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GGT1—hepatitis B	1.63e-05	0.000118	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—hepatitis B	1.62e-05	0.000118	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GGT1—hepatitis B	1.62e-05	0.000118	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT1—hepatitis B	1.62e-05	0.000118	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.6e-05	0.000117	CbGpPWpGaD
Imatinib—ALB—Hemostasis—F2—hepatitis B	1.6e-05	0.000116	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS2—hepatitis B	1.59e-05	0.000116	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-A—hepatitis B	1.59e-05	0.000116	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	1.59e-05	0.000116	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS2—hepatitis B	1.58e-05	0.000115	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GGT1—hepatitis B	1.58e-05	0.000115	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT1—hepatitis B	1.58e-05	0.000115	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CTNNB1—hepatitis B	1.57e-05	0.000114	CbGpPWpGaD
Imatinib—CA2—Metabolism—PTEN—hepatitis B	1.56e-05	0.000114	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKR1B1—hepatitis B	1.56e-05	0.000114	CbGpPWpGaD
Imatinib—KIT—Immune System—IFNG—hepatitis B	1.55e-05	0.000113	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCR5—hepatitis B	1.54e-05	0.000113	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CDKN1A—hepatitis B	1.53e-05	0.000111	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—PTEN—hepatitis B	1.53e-05	0.000111	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NFKB1—hepatitis B	1.52e-05	0.000111	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GGT1—hepatitis B	1.51e-05	0.00011	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT1—hepatitis B	1.51e-05	0.00011	CbGpPWpGaD
Imatinib—LCK—Disease—CCR5—hepatitis B	1.51e-05	0.00011	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP2A6—hepatitis B	1.51e-05	0.00011	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—hepatitis B	1.5e-05	0.000109	CbGpPWpGaD
Imatinib—CA1—Metabolism—PTEN—hepatitis B	1.5e-05	0.000109	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.5e-05	0.000109	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT2—hepatitis B	1.5e-05	0.000109	CbGpPWpGaD
Imatinib—LCK—Disease—HLA-A—hepatitis B	1.47e-05	0.000107	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IFNG—hepatitis B	1.47e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CDKN1A—hepatitis B	1.47e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—PTEN—hepatitis B	1.47e-05	0.000107	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCR5—hepatitis B	1.46e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NFKB1—hepatitis B	1.46e-05	0.000106	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR4—hepatitis B	1.46e-05	0.000106	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-DRB1—hepatitis B	1.46e-05	0.000106	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.44e-05	0.000105	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—hepatitis B	1.42e-05	0.000103	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TGFB1—hepatitis B	1.41e-05	0.000102	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—hepatitis B	1.4e-05	0.000102	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—hepatitis B	1.39e-05	0.000101	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—hepatitis B	1.39e-05	0.000101	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—hepatitis B	1.38e-05	0.000101	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL10—hepatitis B	1.36e-05	9.93e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT2—hepatitis B	1.36e-05	9.92e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CTNNB1—hepatitis B	1.33e-05	9.71e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—F2—hepatitis B	1.33e-05	9.65e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—hepatitis B	1.32e-05	9.65e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.32e-05	9.62e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—hepatitis B	1.32e-05	9.61e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTEN—hepatitis B	1.32e-05	9.6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCR5—hepatitis B	1.32e-05	9.6e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—hepatitis B	1.31e-05	9.55e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—hepatitis B	1.31e-05	9.55e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—hepatitis B	1.31e-05	9.52e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CDKN1A—hepatitis B	1.3e-05	9.48e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—PTEN—hepatitis B	1.3e-05	9.46e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP2A6—hepatitis B	1.3e-05	9.45e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKB1—hepatitis B	1.29e-05	9.42e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—hepatitis B	1.29e-05	9.4e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS2—hepatitis B	1.28e-05	9.32e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—hepatitis B	1.28e-05	9.32e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CTNNB1—hepatitis B	1.26e-05	9.19e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—F2—hepatitis B	1.25e-05	9.14e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—hepatitis B	1.25e-05	9.08e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CDKN1A—hepatitis B	1.23e-05	8.98e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CTNNB1—hepatitis B	1.23e-05	8.96e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PTEN—hepatitis B	1.23e-05	8.96e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKB1—hepatitis B	1.22e-05	8.91e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—hepatitis B	1.22e-05	8.87e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.21e-05	8.78e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CDKN1A—hepatitis B	1.2e-05	8.76e-05	CbGpPWpGaD
Imatinib—KIT—Disease—PTEN—hepatitis B	1.2e-05	8.74e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—hepatitis B	1.19e-05	8.65e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—hepatitis B	1.18e-05	8.6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—hepatitis B	1.18e-05	8.58e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CTNNB1—hepatitis B	1.18e-05	8.57e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT1—hepatitis B	1.18e-05	8.56e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGT1—hepatitis B	1.18e-05	8.56e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT2—hepatitis B	1.17e-05	8.54e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CTNNB1—hepatitis B	1.16e-05	8.48e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.16e-05	8.48e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—hepatitis B	1.16e-05	8.43e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—hepatitis B	1.16e-05	8.43e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT2—hepatitis B	1.16e-05	8.42e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CDKN1A—hepatitis B	1.15e-05	8.37e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—hepatitis B	1.15e-05	8.36e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PTEN—hepatitis B	1.15e-05	8.35e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKB1—hepatitis B	1.14e-05	8.31e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CDKN1A—hepatitis B	1.14e-05	8.29e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CTNNB1—hepatitis B	1.14e-05	8.28e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP2A6—hepatitis B	1.14e-05	8.28e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTEN—hepatitis B	1.14e-05	8.27e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—F2—hepatitis B	1.13e-05	8.23e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDKN1A—hepatitis B	1.11e-05	8.09e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PTEN—hepatitis B	1.11e-05	8.07e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CTNNB1—hepatitis B	1.11e-05	8.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKB1—hepatitis B	1.1e-05	8.03e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.09e-05	7.91e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDKN1A—hepatitis B	1.08e-05	7.88e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—PTEN—hepatitis B	1.08e-05	7.86e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—hepatitis B	1.08e-05	7.84e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKB1—hepatitis B	1.07e-05	7.83e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.07e-05	7.8e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—hepatitis B	1.06e-05	7.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.06e-05	7.73e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCR5—hepatitis B	1.06e-05	7.7e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT2—hepatitis B	1.05e-05	7.67e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CTNNB1—hepatitis B	1.05e-05	7.64e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT2—hepatitis B	1.03e-05	7.49e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—hepatitis B	1.03e-05	7.48e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CDKN1A—hepatitis B	1.02e-05	7.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTEN—hepatitis B	1.02e-05	7.45e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGT1—hepatitis B	1.01e-05	7.37e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT1—hepatitis B	1.01e-05	7.37e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.01e-05	7.34e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—hepatitis B	9.94e-06	7.24e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.9e-06	7.21e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT2—hepatitis B	9.68e-06	7.05e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT2—hepatitis B	9.6e-06	6.99e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—hepatitis B	9.53e-06	6.94e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—hepatitis B	9.5e-06	6.92e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—hepatitis B	9.48e-06	6.91e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—hepatitis B	9.45e-06	6.88e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—hepatitis B	9.41e-06	6.85e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.22e-06	6.72e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CTNNB1—hepatitis B	9.12e-06	6.64e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT1—hepatitis B	9.09e-06	6.62e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT1—hepatitis B	9.09e-06	6.62e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP2A6—hepatitis B	9.07e-06	6.61e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—F2—hepatitis B	9.07e-06	6.61e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—hepatitis B	8.92e-06	6.5e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CDKN1A—hepatitis B	8.91e-06	6.49e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—PTEN—hepatitis B	8.89e-06	6.47e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT1—hepatitis B	8.87e-06	6.46e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT1—hepatitis B	8.87e-06	6.46e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKB1—hepatitis B	8.85e-06	6.44e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—hepatitis B	8.73e-06	6.36e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—hepatitis B	8.65e-06	6.3e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—hepatitis B	8.64e-06	6.29e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CTNNB1—hepatitis B	8.62e-06	6.28e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—hepatitis B	8.48e-06	6.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	8.46e-06	6.16e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—hepatitis B	8.45e-06	6.15e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CTNNB1—hepatitis B	8.42e-06	6.13e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CDKN1A—hepatitis B	8.42e-06	6.13e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—hepatitis B	8.4e-06	6.12e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PTEN—hepatitis B	8.4e-06	6.12e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—hepatitis B	8.38e-06	6.11e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT1—hepatitis B	8.36e-06	6.09e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT1—hepatitis B	8.36e-06	6.09e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKB1—hepatitis B	8.36e-06	6.09e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT1—hepatitis B	8.29e-06	6.04e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT1—hepatitis B	8.29e-06	6.04e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.28e-06	6.03e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CDKN1A—hepatitis B	8.23e-06	5.99e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTEN—hepatitis B	8.21e-06	5.98e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT2—hepatitis B	8.2e-06	5.98e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CTNNB1—hepatitis B	8.16e-06	5.94e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—hepatitis B	8.11e-06	5.91e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—hepatitis B	8.05e-06	5.86e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDKN1A—hepatitis B	7.97e-06	5.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PTEN—hepatitis B	7.95e-06	5.79e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKB1—hepatitis B	7.91e-06	5.76e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—hepatitis B	7.82e-06	5.7e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—hepatitis B	7.68e-06	5.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—hepatitis B	7.61e-06	5.54e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.55e-06	5.5e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—hepatitis B	7.49e-06	5.46e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CTNNB1—hepatitis B	7.35e-06	5.35e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDKN1A—hepatitis B	7.18e-06	5.23e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PTEN—hepatitis B	7.16e-06	5.22e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—hepatitis B	7.16e-06	5.22e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKB1—hepatitis B	7.13e-06	5.19e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—hepatitis B	7.09e-06	5.17e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—hepatitis B	7.08e-06	5.16e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—hepatitis B	7.08e-06	5.16e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	7e-06	5.1e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—hepatitis B	6.96e-06	5.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—hepatitis B	6.92e-06	5.04e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—hepatitis B	6.92e-06	5.04e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—hepatitis B	6.8e-06	4.96e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—hepatitis B	6.74e-06	4.91e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTEN—hepatitis B	6.66e-06	4.85e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTEN—hepatitis B	6.6e-06	4.81e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—hepatitis B	6.59e-06	4.8e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTEN—hepatitis B	6.59e-06	4.8e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.45e-06	4.7e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTEN—hepatitis B	6.4e-06	4.66e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—hepatitis B	6.39e-06	4.65e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—hepatitis B	6.33e-06	4.61e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—hepatitis B	6.25e-06	4.55e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTEN—hepatitis B	6.14e-06	4.47e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—hepatitis B	6.11e-06	4.45e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—hepatitis B	5.94e-06	4.32e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	5.9e-06	4.3e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	5.76e-06	4.2e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTEN—hepatitis B	5.75e-06	4.19e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—hepatitis B	5.73e-06	4.17e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKB1—hepatitis B	5.72e-06	4.17e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—hepatitis B	5.55e-06	4.04e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—hepatitis B	5.46e-06	3.98e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—hepatitis B	5.46e-06	3.98e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—hepatitis B	5.42e-06	3.95e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—hepatitis B	5.25e-06	3.82e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—hepatitis B	5.13e-06	3.73e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—hepatitis B	4.97e-06	3.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—hepatitis B	4.89e-06	3.56e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—hepatitis B	4.83e-06	3.52e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTEN—hepatitis B	4.77e-06	3.48e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—hepatitis B	4.76e-06	3.47e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—hepatitis B	4.72e-06	3.44e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—hepatitis B	4.47e-06	3.26e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—hepatitis B	4.45e-06	3.24e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—hepatitis B	4.41e-06	3.21e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTEN—hepatitis B	4.11e-06	2.99e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—hepatitis B	3.92e-06	2.86e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—hepatitis B	3.77e-06	2.74e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTEN—hepatitis B	3.69e-06	2.69e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTEN—hepatitis B	3.6e-06	2.62e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—hepatitis B	3.59e-06	2.62e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTEN—hepatitis B	3.39e-06	2.47e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTEN—hepatitis B	3.36e-06	2.45e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—hepatitis B	2.91e-06	2.12e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTEN—hepatitis B	2.87e-06	2.09e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTEN—hepatitis B	2.22e-06	1.62e-05	CbGpPWpGaD
